Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259,969 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.
Yellapantula V, Hultcrantz M, Rustad EH, Wasserman E, Londono D, Cimera R, Ciardiello A, Landau H, Akhlaghi T, Mailankody S, Patel M, Medina-Martinez JS, Ossa JEA, Levine MF, Bolli N, Maura F, Dogan A, Papaemmanuil E, Zhang Y, Landgren O. Yellapantula V, et al. Among authors: zhang y. Blood Cancer J. 2020 Jan 30;10(1):11. doi: 10.1038/s41408-020-0279-4. Blood Cancer J. 2020. PMID: 32001687 Free PMC article.
PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation.
Xiao W, Bharadwaj M, Levine M, Farnhoud N, Pastore F, Getta BM, Hultquist A, Famulare C, Medina JS, Patel MA, Gao Q, Lewis N, Pichardo J, Baik J, Shaffer B, Giralt S, Rampal R, Devlin S, Cimera R, Zhang Y, E Arcila M, Papaemmanuil E, Levine RL, Roshal M. Xiao W, et al. Among authors: zhang y. Blood Adv. 2018 Dec 11;2(23):3526-3539. doi: 10.1182/bloodadvances.2018023531. Blood Adv. 2018. PMID: 30530780 Free PMC article.
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
Jia L, Carlo MI, Khan H, Nanjangud GJ, Rana S, Cimera R, Zhang Y, Hakimi AA, Verma AK, Al-Ahmadie HA, Fine SW, Gopalan A, Sirintrapun SJ, Tickoo SK, Reuter VE, Gartrell BA, Chen YB. Jia L, et al. Among authors: zhang y. Mod Pathol. 2019 Sep;32(9):1329-1343. doi: 10.1038/s41379-019-0273-1. Epub 2019 Apr 12. Mod Pathol. 2019. PMID: 30980040 Free PMC article.
Divergent clonal evolution of a common precursor to mantle cell lymphoma and classic Hodgkin lymphoma.
Tashkandi H, Petrova-Drus K, Batlevi CL, Arcila ME, Roshal M, Sen F, Yao J, Baik J, Bilger A, Singh J, de Frank S, Kumar A, Aryeequaye R, Zhang Y, Dogan A, Xiao W. Tashkandi H, et al. Among authors: zhang y. Cold Spring Harb Mol Case Stud. 2019 Dec 13;5(6):a004259. doi: 10.1101/mcs.a004259. Print 2019 Dec. Cold Spring Harb Mol Case Stud. 2019. PMID: 31395597 Free PMC article.
Clonally-Related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications.
Kumar P, Uppal M, Xiao W, Dogan A, Roshal M, Gao Q, Aypar U, Zhang Y, Arcila ME, Moung C, Yao J, Nafa K, Yu W, Syed MH, Park J, Kumar A, Ho C. Kumar P, et al. Among authors: zhang y. Leuk Lymphoma. 2020 Feb;61(2):460-464. doi: 10.1080/10428194.2019.1675876. Epub 2019 Oct 15. Leuk Lymphoma. 2020. PMID: 31612754 Free PMC article. No abstract available.
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma.
Yellapantula V, Hultcrantz M, Rustad EH, Wasserman E, Londono D, Cimera R, Ciardiello A, Landau H, Akhlaghi T, Mailankody S, Patel M, Medina-Martinez JS, Arango Ossa JE, Levine MF, Bolli N, Maura F, Dogan A, Papaemmanuil E, Zhang Y, Landgren O. Yellapantula V, et al. Among authors: zhang y. Blood Cancer J. 2019 Dec 11;9(12):101. doi: 10.1038/s41408-019-0264-y. Blood Cancer J. 2019. PMID: 31827071 Free PMC article.
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma.
Eveillard M, Rustad E, Roshal M, Zhang Y, Ciardiello A, Korde N, Hultcrantz M, Lu S, Shah U, Hassoun H, Smith E, Lesokhin A, Mailankody S, Landgren O, Thoren K. Eveillard M, et al. Among authors: zhang y. Br J Haematol. 2020 Jun;189(5):904-907. doi: 10.1111/bjh.16443. Epub 2020 Feb 5. Br J Haematol. 2020. PMID: 32026474 Free PMC article.
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple Myeloma.
Liu Y, Jelloul F, Zhang Y, Bhavsar T, Ho C, Rao M, Lewis NE, Cimera R, Baik J, Sigler A, Sen F, Yabe M, Roshal M, Landgren O, Dogan A, Xiao W. Liu Y, et al. Among authors: zhang y. Am J Surg Pathol. 2020 Jun;44(6):838-848. doi: 10.1097/PAS.0000000000001459. Am J Surg Pathol. 2020. PMID: 32118627 Free PMC article.
259,969 results
You have reached the last available page of results. Please see the User Guide for more information.